Dianthus Therapeutics Cash Flow Statement (2017-2025) | DNTH

Cash Flow Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -15.73M-6.91M-8.04M-11.16M-13.66M-16.02M-16.68M-14.83M-17.71M-20.99M-23.24M-20.01M-19.08M-17.68M-7.84M-10.05M-7.08M-11.09M-14.73M-10.51M-13.62M-17.50M-25.45M-27.93M-29.39M-31.52M-36.63M
Depreciation and Depletion 0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M
Share-based Compensation 0.31M0.56M0.77M1.43M3.05M3.68M2.55M2.58M2.60M2.76M2.06M2.74M1.91M1.84M0.66M0.51M0.53M0.46M1.18M0.73M2.04M3.10M3.84M3.92M5.32M5.71M5.79M
Gains from Sales and Divestitures 0.91M0.08M0.01M0.01M
Gains from Investment Securities -0.00M-0.07M1.30M-3.32M3.37M-0.05M0.47M0.04M0.12M0.48M5.93M0.43M4.99M
Non-cash Items 1.79M0.57M1.70M0.70M3.18M51.07M1.03M49.03M24.87M1.84M2.18M2.33M
Cash from Operations -5.44M-8.23M-9.60M-9.11M-10.55M-12.62M-14.94M-15.03M-11.51M-15.63M-16.66M-19.74M-16.85M16.38M-8.85M-10.28M-4.73M-9.99M-11.85M-14.94M-14.53M-21.27M-27.44M-27.63M-23.89M-30.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.31M0.30M0.29M0.10M-0.01M-0.12M-0.11M0.43M0.40M0.36M0.21M0.33M0.53M0.52M0.42M2.34M2.74M1.90M1.10M2.31M
Depreciation & Amortization (CF) 0.12M0.13M0.15M0.16M0.21M0.36M0.42M0.45M0.48M0.48M0.49M0.51M0.48M0.47M0.47M0.42M0.01M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M
Change in Working Capital
Change in Receivables 1.00M-0.96M4.96M
Change in Account Payables 0.75M-2.29M1.21M-0.21M1.11M0.40M-0.66M0.23M-0.20M0.77M1.14M1.40M-2.39M0.53M-0.34M-4.73M3.01M0.77M1.60M-2.99M3.25M5.65M2.28M-1.50M3.09M3.00M
Change in Accured Expenses 0.19M1.76M-1.16M2.08M0.82M0.50M-1.64M2.49M0.52M3.71M-2.55M-0.86M-0.62M0.94M1.52M-3.34M-1.68M
Investing Activities
Capital Expenditures 0.39M0.32M0.16M0.69M2.62M4.21M1.25M1.13M0.53M0.15M0.13M0.03M0.13M-0.05M0.03M0.01M0.02M0.07M0.01M0.03M0.02M0.03M0.03M0.02M0.05M0.01M
Sales of Property, Plant and Equipment 1.51M0.57M
Change in Acquisitions & Divestments 7.50M32.50M64.34M44.62M30.50M2.00M22.00M21.89M15.90M18.00M15.00M8.00M19.00M85.00M82.14M59.60M78.57M
Cash from Investing Activities -0.39M-0.18M-0.16M-0.67M-2.48M-88.39M-12.73M-43.82M63.81M-5.72M25.39M-40.14M-0.13M-6.88M-12.66M18.13M21.86M-11.51M-8.24M-5.51M1.17M-259.36M-23.11M14.79M26.45M-201.28M
Financing Activities
Other financing activities 0.17M1.69M0.76M0.48M0.16M12.42M2.24M
Debt Issuance and Repayment
Long-Term Debt Issuances 0.38M
Long-Term Debt Repayments 0.38M
Change in Capital Stock
Shares Issued 0.56M60.31M1.12M64.60M-0.05M0.01M0.27M0.05M0.30M38.59M0.13M0.47M271.67M
Preferred Shares Issued 2.00M
Misc.
Cash from Financing Activities 2.00M-0.17M143.53M-0.73M-0.48M0.56M60.73M0.10M0.91M1.12M0.05M96.63M138.44M-4.87M217.85M-2.20M0.30M39.68M0.16M0.57M274.51M
Change in Cash -3.83M-8.41M-9.94M133.75M-13.76M-101.49M-27.10M1.87M52.40M-20.44M9.86M-59.88M-16.93M106.12M-21.52M7.85M17.13M116.94M-24.96M197.40M-15.55M-280.33M-10.88M-12.68M3.12M42.68M
Beginning Cash Balance 63.78M63.78M59.82M9.94M39.68M173.43M159.84M58.34M31.24M33.11M85.51M65.07M136.29M141.68M131.65M71.77M-69.24M36.88M15.37M23.15M40.34M157.28M132.32M329.72M314.01M33.67M22.79M10.12M13.30M
Free Cash Flow -5.83M-8.55M-9.77M-9.79M-13.17M-16.83M-16.19M-16.16M-12.04M-15.78M-16.79M-19.77M-16.98M16.42M-8.88M-10.30M-4.75M-10.06M-11.86M-14.97M-14.54M-21.29M-27.48M-27.65M-23.94M-30.56M
Net Cash Flow -3.83M-8.41M-9.94M133.75M-13.76M-101.49M-27.10M1.87M52.40M-20.44M9.86M-59.88M-16.93M106.12M-21.52M7.85M17.13M116.94M-24.96M197.40M-15.55M-280.33M-10.88M-12.68M3.12M42.68M